Prawo i regulacje · 16/12/2019

U.S. Federal Trade Commission Approves Pfizer's Acquisition of BioNTech, Following Antitrust Review

The U.S. Federal Trade Commission has approved Pfizer's acquisition of BioNTech, following a thorough antitrust review, allowing the deal to move forward and create a leading player in the global vaccine market